Investment Thesis
Synopsys demonstrates strong revenue growth (+15.1% YoY) and exceptional cash generation (34.1% FCF margin), with a fortress balance sheet and healthy liquidity position. However, profitability metrics are concerning with collapsing net income (-0.1% YoY), diluted EPS down 44.6% YoY, and net margin compressed to 2.7% despite strong gross margins, suggesting operational challenges that require monitoring.
SNPS Strengths
- Strong revenue growth of 15.1% YoY demonstrates market demand and business expansion
- Exceptional free cash flow generation at $821.5M with 34.1% FCF margin indicates efficient core operations
- Fortress balance sheet with $30.5B equity, 0.33x debt-to-equity ratio, and 153.4x interest coverage providing financial flexibility
- High gross margin of 73.5% reflects strong pricing power and product differentiation
- Solid liquidity with 1.36x current ratio and $2.1B cash position
SNPS Risks
- Net income essentially flat YoY despite 15.1% revenue growth, indicating margin compression and operational inefficiency
- Diluted EPS collapsed 44.6% YoY, signaling significant shareholder value destruction from increased shares or non-operating charges
- Operating margin of 8.4% is thin relative to gross margin of 73.5%, suggesting high operating expenses consuming most gross profit
- Net margin of only 2.7% leaves minimal buffer for any adverse business developments or economic headwinds
- Return on equity (0.2%) and ROA (0.1%) are extremely poor relative to equity and asset base, indicating poor capital deployment efficiency
Key Metrics to Watch
- Operating margin trend - need to see expansion above 8.4% to justify premium valuation
- Net income growth reconciliation - critical to understand whether profit decline is operational or non-recurring
- Free cash flow sustainability - monitor if 34.1% FCF margin can be maintained as revenue growth moderates
- Operating expense ratio - track whether SG&A and R&D spending normalize or remain elevated
- Return on invested capital - improve ROIC metrics to demonstrate effective use of $30.5B equity base
SNPS Financial Metrics
SNPS Profitability Ratios
SNPS Balance Sheet & Liquidity
SNPS 5-Year Financial Trend
5-Year Trend Summary: SYNOPSYS INC's revenue has grown significantly by 68% over the 5-year period, indicating strong business expansion. The most recent EPS of $7.92 reflects profitable operations.
SNPS Growth Metrics (YoY)
SNPS Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $1.5B | $65.0M | $0.34 |
| Q3 2025 | $1.5B | $242.5M | $1.50 |
| Q2 2025 | $1.5B | $292.1M | $1.88 |
| Q1 2025 | $1.5B | $295.7M | $1.89 |
| Q3 2024 | $1.4B | $336.3M | $2.17 |
| Q2 2024 | $1.3B | $272.9M | $1.76 |
| Q1 2024 | $1.4B | $271.5M | $1.75 |
| Q3 2023 | $1.2B | $222.6M | $1.43 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
SNPS Capital Allocation
SNPS SEC Filings
Access official SEC EDGAR filings for SYNOPSYS INC (CIK: 0000883241)